| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 4: Evans John M., Director
Received 25,000 shares by exercise or conversion ($25.8K) · Sold 25,000 shares ($589K) · Received 25,000 shares by exercise or conversion ($25.8K) · 1 more |
| 16 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 02 Oct 2026 |
Form 4: Cavanagh Bethany J, SVP, Finance and Treasurer
Sold 187 shares ($4.56K) |
| 25 Sep 2026 |
Form 4: Ciaramella Giuseppe, President
Gave 123,407 shares as a gift |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 04 Aug 2026 | 10-Q |
| 04 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 29 Jul 2026 |
Form 4: Simon Amy, Chief Medical Officer
Sold 16,667 shares ($429K) |
| 27 Jul 2026 | 144 |
| 02 Jul 2026 |
Form 4: Simon Amy, Chief Medical Officer
Sold 373 shares ($13K) |
| 01 Jul 2026 |
Form 4: Evans John M., Director
Received 25,000 shares by exercise or conversion ($19K) · Sold 25,000 shares ($887K) · Received 25,000 shares by exercise or conversion ($25.8K) · 1 more |
| 30 Jun 2026 | 144 |
| 29 Jun 2026 | 144 |
| 29 Jun 2026 |
Form 4: Fmr Llc, 10% owner
Sold 33,372 shares ($1.17M) · Sold 251,488 shares ($8.87M) |
| 22 Jun 2026 |
Form 4: Ciaramella Giuseppe, President
Received 35,505 shares by exercise or conversion ($34.2K) |
| 08 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 05 Jun 2026 |
Form 4: Shaw Christi, Director
Granted 19,676 Stock Option (Right to Buy) |
| 05 Jun 2026 |
Form 4: Walsh Kathleen E, Director
Granted 19,676 Stock Option (Right to Buy) |
Loading...